176 related articles for article (PubMed ID: 16408072)
1. Host sphingolipid biosynthesis as a target for hepatitis C virus therapy.
Sakamoto H; Okamoto K; Aoki M; Kato H; Katsume A; Ohta A; Tsukuda T; Shimma N; Aoki Y; Arisawa M; Kohara M; Sudoh M
Nat Chem Biol; 2005 Nov; 1(6):333-7. PubMed ID: 16408072
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts.
Aizaki H; Lee KJ; Sung VM; Ishiko H; Lai MM
Virology; 2004 Jul; 324(2):450-61. PubMed ID: 15207630
[TBL] [Abstract][Full Text] [Related]
3. Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection.
Njoroge FG; Chen KX; Shih NY; Piwinski JJ
Acc Chem Res; 2008 Jan; 41(1):50-9. PubMed ID: 18193821
[TBL] [Abstract][Full Text] [Related]
4. Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model.
Umehara T; Sudoh M; Yasui F; Matsuda C; Hayashi Y; Chayama K; Kohara M
Biochem Biophys Res Commun; 2006 Jul; 346(1):67-73. PubMed ID: 16750511
[TBL] [Abstract][Full Text] [Related]
5. Targeting lipid metabolism in the treatment of hepatitis C virus infection.
Amemiya F; Maekawa S; Itakura Y; Kanayama A; Matsui A; Takano S; Yamaguchi T; Itakura J; Kitamura T; Inoue T; Sakamoto M; Yamauchi K; Okada S; Yamashita A; Sakamoto N; Itoh M; Enomoto N
J Infect Dis; 2008 Feb; 197(3):361-70. PubMed ID: 18248300
[TBL] [Abstract][Full Text] [Related]
6. Network based analysis of hepatitis C virus core and NS4B protein interactions.
Tripathi LP; Kataoka C; Taguwa S; Moriishi K; Mori Y; Matsuura Y; Mizuguchi K
Mol Biosyst; 2010 Dec; 6(12):2539-53. PubMed ID: 20953506
[TBL] [Abstract][Full Text] [Related]
7. Additive effect of ethanol and HCV subgenomic replicon expression on COX-2 protein levels and activity.
Trujillo-Murillo K; Alvarez-Martínez O; Garza-Rodríguez L; Martínez-Rodríguez H; Bosques-Padilla F; Ramos-Jiménez J; Barrera-Saldaña H; Rincón-Sánchez AR; Rivas-Estilla AM
J Viral Hepat; 2007 Sep; 14(9):608-17. PubMed ID: 17697012
[TBL] [Abstract][Full Text] [Related]
8. Chemical genetics approach to hepatitis C virus replication: cyclophilin as a target for anti-hepatitis C virus strategy.
Watashi K; Shimotohno K
Rev Med Virol; 2007; 17(4):245-52. PubMed ID: 17299803
[TBL] [Abstract][Full Text] [Related]
9. Evaluation systems for anti-HCV drugs.
Moriishi K; Matsuura Y
Adv Drug Deliv Rev; 2007 Oct; 59(12):1213-21. PubMed ID: 17720275
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus virology and new treatment targets.
Meier V; Ramadori G
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
[TBL] [Abstract][Full Text] [Related]
11. [Role of lipid rafts in hepatitis C virus life cycle].
Grek M; Bartkowiak J; Sidorkiewicz M
Postepy Biochem; 2007; 53(4):334-43. PubMed ID: 19024898
[TBL] [Abstract][Full Text] [Related]
12. Identification of the nonstructural protein 4B of hepatitis C virus as a factor that inhibits the antiviral activity of interferon-alpha.
Xu J; Liu S; Xu Y; Tien P; Gao G
Virus Res; 2009 Apr; 141(1):55-62. PubMed ID: 19185598
[TBL] [Abstract][Full Text] [Related]
13. Polypyrimidine-tract-binding protein is a component of the HCV RNA replication complex and necessary for RNA synthesis.
Aizaki H; Choi KS; Liu M; Li YJ; Lai MM
J Biomed Sci; 2006 Jul; 13(4):469-80. PubMed ID: 16691359
[TBL] [Abstract][Full Text] [Related]
14. Host cell responses induced by hepatitis C virus binding.
Fang X; Zeisel MB; Wilpert J; Gissler B; Thimme R; Kreutz C; Maiwald T; Timmer J; Kern WV; Donauer J; Geyer M; Walz G; Depla E; von Weizsäcker F; Blum HE; Baumert TF
Hepatology; 2006 Jun; 43(6):1326-36. PubMed ID: 16729312
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus genetic variability in patients undergoing antiviral therapy.
Cristina J; del Pilar Moreno M; Moratorio G
Virus Res; 2007 Aug; 127(2):185-94. PubMed ID: 17449128
[TBL] [Abstract][Full Text] [Related]
16. Host factors involved in the replication of hepatitis C virus.
Moriishi K; Matsuura Y
Rev Med Virol; 2007; 17(5):343-54. PubMed ID: 17563922
[TBL] [Abstract][Full Text] [Related]
17. [Suppression of hepatitis C virus with the reagent targetting host factors].
Hirata Y; Sudoh M; Kohara M
Uirusu; 2008 Dec; 58(2):207-13. PubMed ID: 19374199
[TBL] [Abstract][Full Text] [Related]
18. Boceprevir, an NS3 protease inhibitor of HCV.
Berman K; Kwo PY
Clin Liver Dis; 2009 Aug; 13(3):429-39. PubMed ID: 19628159
[TBL] [Abstract][Full Text] [Related]
19. Trans-encapsidation of hepatitis C virus subgenomic replicon RNA with viral structure proteins.
Ishii K; Murakami K; Hmwe SS; Zhang B; Li J; Shirakura M; Morikawa K; Suzuki R; Miyamura T; Wakita T; Suzuki T
Biochem Biophys Res Commun; 2008 Jul; 371(3):446-50. PubMed ID: 18445476
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C Virus Induces the Localization of Lipid Rafts to Autophagosomes for Its RNA Replication.
Kim JY; Wang L; Lee J; Ou JJ
J Virol; 2017 Oct; 91(20):. PubMed ID: 28747506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
